CTI BIOPHARMA CORP Quarterly Return On Equity in % from Q1 2012 to Q1 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cti Biopharma Corp quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q1 2023.
  • Cti Biopharma Corp Return On Equity for the quarter ending March 31, 2023 was 426 %.
  • Cti Biopharma Corp annual Return On Equity for 2022 was 550 %.
  • Cti Biopharma Corp annual Return On Equity for 2021 was -299 %, a 137% decline from 2020.
  • Cti Biopharma Corp annual Return On Equity for 2020 was -126 %, a 2.4% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 426 +1.04K Jan 1, 2023 Mar 31, 2023
Q4 2022 550 +849 Oct 1, 2022 Dec 31, 2022
Q3 2022 971 +1.15K Jul 1, 2022 Sep 30, 2022
Q2 2022 -5.11K -4.96K -3438% Apr 1, 2022 Jun 30, 2022
Q1 2022 -616 -481 -356% Jan 1, 2022 Mar 31, 2022
Q4 2021 -299 -173 -137% Oct 1, 2021 Dec 31, 2021
Q3 2021 -182 -55.3 -43.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -144 -0.27 -0.19% Apr 1, 2021 Jun 30, 2021
Q1 2021 -135 +28.1 +17.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -126 +3.1 +2.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -127 -48.7 -62.3% Jul 1, 2020 Sep 30, 2020
Q2 2020 -144 -66.3 -85.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -163 -95.2 -140% Jan 1, 2020 Mar 31, 2020
Q4 2019 -129 -81.6 -170% Oct 1, 2019 Dec 31, 2019
Q3 2019 -78.1 +7.29 +8.54% Jul 1, 2019 Sep 30, 2019
Q2 2019 -77.8 +12.1 +13.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -68 -5.99 -9.67% Jan 1, 2019 Mar 31, 2019
Q4 2018 -47.9 +175 +78.5% Oct 1, 2018 Dec 31, 2018
Q3 2018 -85.4 +117 +57.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -89.8 +320 +78.1% Apr 1, 2018 Jun 30, 2018
Q1 2018 -62 +582 +90.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 -223 -36.6 -19.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -203 -14.3 -7.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -410 -141 -52.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -644 -52.1 -8.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -186 +2.4K +92.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -188 +5.48K +96.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -268 +471 +63.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -592 -98.5 -20% Jan 1, 2016 Mar 31, 2016
Q4 2015 -2.58K -2.14K -484% Oct 1, 2015 Dec 31, 2015
Q3 2015 -5.67K -5.48K -2922% Jul 1, 2015 Sep 30, 2015
Q2 2015 -739 -401 -119% Apr 1, 2015 Jun 30, 2015
Q1 2015 -494 -176 -55.6% Jan 1, 2015 Mar 31, 2015
Q4 2014 -442 -152 -52.4% Oct 1, 2014 Dec 31, 2014
Q3 2014 -188 +396 +67.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 -338 +396 +53.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -317 +1.39K +81.4% Jan 1, 2014 Mar 31, 2014
Q4 2013 -290 +1.71K +85.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 -583 +1.81K +75.6% Jul 1, 2013 Sep 30, 2013
Q2 2013 -734 +181 +19.8% Apr 1, 2013 Jun 30, 2013
Q1 2013 -1.71K -1.3K -316% Jan 1, 2013 Mar 31, 2013
Q4 2012 -2K Oct 1, 2012 Dec 31, 2012
Q3 2012 -2.39K Jul 1, 2012 Sep 30, 2012
Q2 2012 -915 Apr 1, 2012 Jun 30, 2012
Q1 2012 -410 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.